友芝友生物-B(02496)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02496 友芝友生物-B

未开盘 12-05 09:20:02

7.090

+0.000

0.00%

最高7.090	最低7.090	成交量0.00
今开7.090	昨收7.090	日振幅0.00%
总市值13.74亿	流通市值7.90亿	总股本1.94亿
成交额0.00	换手率0.00%	流通股本1.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02496","market":"HK","secType":"STK","nameCN":"友芝友生物-B","latestPrice":7.09,"timestamp":1764897602116,"preClose":7.09,"halted":0,"volume":0,"delay":0,"floatShares":111468814,"shares":193849200,"eps":-0.5543571997010673,"marketStatus":"未开盘","change":0,"latestTime":"12-05 09:20:02","open":7.09,"high":7.09,"low":7.09,"amount":0,"amplitude":0,"askPrice":7.33,"askSize":200,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.4432455099371775,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":0,"adr":0,"listingDate":1695571200000,"exchange":"SEHK","adjPreClose":7.09,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02496","defaultTab":"news","newsList":[{"id":"2588031469","title":"友芝友生物-B(02496)于《实验血液学与肿瘤学》上发表M 701恶性腹水II期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2588031469","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588031469?lang=zh_cn&edition=full","pubTime":"2025-12-02 18:09","pubTimestamp":1764670177,"startTime":"0","endTime":"0","summary":"II期研究旨在评估M701腹腔内输注疗法对出现中至大量恶性腹水的晚期上皮性肿瘤患者的疗效与安全性。本研究共纳入84名患者，其中43名患者被分配至M701组，接受腹腔穿刺及腹腔内M701输注。与对照组患者相比，M701组患者的总生存时间获得延长。在M701组别中未观察到任何其他严重不良反应事件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"友芝友生物-B(02496)于《实验血液学与肿瘤学》上发表M 701恶性腹水II期数据","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2583665794","title":"深耕双抗领域15年，友芝友生物周鹏飞：中国创新药正在走向产业高潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2583665794","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583665794?lang=zh_cn&edition=full","pubTime":"2025-11-15 13:56","pubTimestamp":1763186186,"startTime":"0","endTime":"0","summary":"M701即将申请上市，友芝友生物将其中国区权益以超过20亿元的预期销售额转让给正大天晴，自己保留海外权益和销售提成。在双抗领域的蓝海中，周鹏飞和他的团队正以坚定的步伐，书写着中国生物医药创新的新篇章。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511151404519505db72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511151404519505db72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06978","BK1161","02496"],"gpt_icon":0},{"id":"2577832867","title":"ORR 72.7%！友芝友生物EpCAM×CD3双抗II期研究中期数据公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2577832867","media":"生物药大时代","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577832867?lang=zh_cn&edition=full","pubTime":"2025-10-20 11:28","pubTimestamp":1760930924,"startTime":"0","endTime":"0","summary":"2025年10月19日，武汉友芝友生物制药股份有限公司宣布，公司自主研发的上皮细胞黏附分子和分化簇3双靶向的在研双特异性抗体药物M701在中国开展的治疗晚期非小细胞肺癌引发的恶性胸水的II期临床研究的中期数据已以大会壁报的形式在2025年欧洲肿瘤内科学会会议上公布。正大天晴将根据研发进展情况，向友芝友生物支付约3.15亿元的首付款及研发里程碑款项，并支付最高不超过7亿元的销售里程碑款项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020113325a4694450&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020113325a4694450&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2576078087","title":"友芝友生物-B(02496)：M701恶性胸水II期研究中期数据在2025年ESMO会议上公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2576078087","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576078087?lang=zh_cn&edition=full","pubTime":"2025-10-19 18:19","pubTimestamp":1760869192,"startTime":"0","endTime":"0","summary":"本研究是一项针对晚期非小细胞肺癌导致的恶性胸水的随机对照、多中心、开放式的II期临床试验。试验组受试者在胸腔穿刺引流后，给予胸腔灌注M701药物。截至2025年3月7日，54名筛选合格的经至少一线全身治疗后病情进展、有症状性恶性胸水的晚期非小细胞肺癌患者，按照1:1随机分组，试验组26名，对照组28名。安全性结果：M701治疗相关不良事件发生率为3.7%，顺铂组为10%，仅1例严重不良事件与M701相关。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2570758200","title":"友芝友生物-B盘中异动 早盘快速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570758200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570758200?lang=zh_cn&edition=full","pubTime":"2025-09-26 11:26","pubTimestamp":1758857191,"startTime":"0","endTime":"0","summary":"2025年09月26日早盘11时26分，友芝友生物-B股票出现异动，股价急速上涨5.24%。截至发稿，该股报6.630港元/股，成交量6200股，换手率0.01%，振幅5.24%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。友芝友生物-B股票所在的生物技术行业中，整体跌幅为2.59%。其相关个股中，云康集团、来凯医药-B、友芝友生物-B涨幅较大，振幅较大的相关个股有华昊中天医药-B、创胜集团-B、来凯医药-B，振幅分别为13.57%、11.09%、9.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926112631a69f04c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250926112631a69f04c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2568427724","title":"友芝友生物-B(02496)：王涛获选举为职工代表监事","url":"https://stock-news.laohu8.com/highlight/detail?id=2568427724","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568427724?lang=zh_cn&edition=full","pubTime":"2025-09-18 16:50","pubTimestamp":1758185448,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B(02496)发布公告，张敬先生因个人职业发展原因而辞去公司职工代表监事职务，自2025年9月18日起生效。公司研发平台部执行总监王涛博士于2025年9月18日获民主选举为第二届监事会职工代表监事。王涛博士的任期自2025年9月18日起生效，并将于第二届监事会结束时届满。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2562849397","title":"友芝友生物-B(02496)发布中期业绩，净亏损5883.4万元，同比收窄25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562849397","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562849397?lang=zh_cn&edition=full","pubTime":"2025-08-26 17:43","pubTimestamp":1756201421,"startTime":"0","endTime":"0","summary":"智通财经APP讯，友芝友生物-B 发布截至2025年6月30日止六个月业绩，收入3718.7万元;净亏损5883.4万元，同比收窄25%;每股基本亏损0.30元。许可费收入主要是公司与正大天晴签订了一项许可合作协定。截至2025年6月30日止六个月，集团就授予许可使用权以实现发展里程碑确认收入470万元。在截至2025年6月30日止六个月，公司根据满足履约义务所付出的努力或投入与预计为满足该履约义务所需的总投入之间的相对比例按进度确认了3250万元的研发服务收入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1335354.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2552566644","title":"友芝友生物-B盘中异动 早盘股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552566644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552566644?lang=zh_cn&edition=full","pubTime":"2025-07-18 10:54","pubTimestamp":1752807258,"startTime":"0","endTime":"0","summary":"2025年07月18日早盘10时54分，友芝友生物-B股票出现异动，股价急速上涨5.45%。截至发稿，该股报5.800港元/股，成交量1800股，换手率0.00%，振幅2.00%。资金方面，该股资金流入1.0358万港元，流出0港元。友芝友生物-B股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，歌礼制药-B、荃信生物-B、乐普生物-B涨幅较大，振幅较大的相关个股有三叶草生物-B、歌礼制药-B、北海康成-B，振幅分别为14.58%、13.81%、13.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507181054189546f2d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507181054189546f2d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2551511186","title":"友芝友生物-B盘中异动 股价大涨13.08%报5.880港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551511186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551511186?lang=zh_cn&edition=full","pubTime":"2025-07-16 11:29","pubTimestamp":1752636593,"startTime":"0","endTime":"0","summary":"2025年07月16日早盘11时29分，友芝友生物-B股票出现波动，股价大幅拉升13.08%。截至发稿，该股报5.880港元/股，成交量3200股，换手率0.00%，振幅12.12%。资金方面，该股资金流入0港元，流出1.6926万港元。友芝友生物-B股票所在的生物技术行业中，整体涨幅为1.05%。其相关个股中，中国抗体-B、友芝友生物-B、派格生物医药-B涨幅较大，振幅较大的相关个股有中国抗体-B、北海康成-B、派格生物医药-B，振幅分别为18.93%、16.28%、13.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716112953a44db29c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716112953a44db29c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2550113686","title":"友芝友生物-B盘中异动 临近收盘急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550113686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550113686?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:40","pubTimestamp":1752133213,"startTime":"0","endTime":"0","summary":"2025年07月10日临近收盘15时40分，友芝友生物-B股票出现波动，股价大幅上涨5.05%。截至发稿，该股报5.200港元/股，成交量6200股，换手率0.01%，振幅4.44%。资金方面，该股资金流入1.652万港元，流出1.494万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。友芝友生物-B股票所在的生物技术行业中，整体跌幅为0.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710154013a6a10abb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710154013a6a10abb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2542499362","title":"友芝友生物-B盘中异动 大幅上涨22.93%报5.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542499362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542499362?lang=zh_cn&edition=full","pubTime":"2025-06-10 13:39","pubTimestamp":1749533958,"startTime":"0","endTime":"0","summary":"2025年06月10日下午盘13时39分，友芝友生物-B股票出现波动，股价大幅拉升22.93%。截至发稿，该股报5.200港元/股，成交量200股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出1040港元。友芝友生物-B股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，友芝友生物-B、晶泰控股、映恩生物-B涨幅较大，振幅较大的相关个股有帝王国际投资、晶泰控股、中国抗体-B，振幅分别为18.60%、18.47%、16.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610133918a4a16b54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610133918a4a16b54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2517063128","title":"友芝友生物-B盘中异动 大幅下跌8.45%报4.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517063128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517063128?lang=zh_cn&edition=full","pubTime":"2025-03-07 11:41","pubTimestamp":1741318883,"startTime":"0","endTime":"0","summary":"2025年03月07日临近午盘11时41分，友芝友生物-B股票出现异动，股价大幅跳水8.45%。截至发稿，该股报4.660港元/股，成交量600股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出2796港元。友芝友生物-B股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，云顶新耀-B、百奥赛图-B、金斯瑞生物科技涨幅较大，振幅较大的相关个股有帝王国际投资、创胜集团-B、云顶新耀-B，振幅分别为45.16%、18.09%、15.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307114123963cf546&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307114123963cf546&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2517905505","title":"友芝友生物-B盘中异动 快速下挫6.41%报5.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517905505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517905505?lang=zh_cn&edition=full","pubTime":"2025-03-06 10:51","pubTimestamp":1741229469,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘10时51分，友芝友生物-B股票出现波动，股价大幅跳水6.41%。截至发稿，该股报5.400港元/股，成交量1800股，换手率0.00%，振幅2.43%。资金方面，该股资金流入0港元，流出9828港元。最近的财报数据显示，该股实现营业收入数据暂无，净利润-8,589.65万港元，每股收益-0.44港元，毛利数据暂无，市盈率-4.95倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。友芝友生物-B股票所在的生物技术行业中，整体涨幅为1.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306105109963b8f68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306105109963b8f68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2513313682","title":"友芝友生物-B盘中异动 大幅下挫5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513313682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513313682?lang=zh_cn&edition=full","pubTime":"2025-02-21 14:07","pubTimestamp":1740118060,"startTime":"0","endTime":"0","summary":"2025年02月21日下午盘14时07分，友芝友生物-B股票出现异动，股价大幅跳水5.58%。截至发稿，该股报6.600港元/股，成交量2000股，换手率0.00%，振幅1.43%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。友芝友生物-B股票所在的生物技术行业中，整体涨幅为3.59%。其相关个股中，创胜集团-B、再鼎医药、科伦博泰生物-B涨幅较大，振幅较大的相关个股有创胜集团-B、北海康成-B、三叶草生物-B，振幅分别为20.00%、18.00%、16.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221140741962ae8f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221140741962ae8f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2509692752","title":"友芝友生物-B盘中异动 临近午盘急速拉升7.63%报7.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509692752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509692752?lang=zh_cn&edition=full","pubTime":"2025-02-07 11:53","pubTimestamp":1738900381,"startTime":"0","endTime":"0","summary":"2025年02月07日临近午盘11时53分，友芝友生物-B股票出现异动，股价大幅上涨7.63%。截至发稿，该股报7.900港元/股，成交量3600股，换手率0.00%，振幅7.63%。资金方面，该股资金流入2.6536万港元，流出0港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。友芝友生物-B股票所在的生物技术行业中，整体跌幅为0.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207115302961ab2b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207115302961ab2b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2495639042","title":"友芝友生物-B盘中异动 临近午盘急速拉升10.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495639042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495639042?lang=zh_cn&edition=full","pubTime":"2024-12-31 11:49","pubTimestamp":1735616989,"startTime":"0","endTime":"0","summary":"2024年12月31日临近午盘11时49分，友芝友生物-B股票出现波动，股价大幅上涨10.18%。截至发稿，该股报7.900港元/股，成交量5200股，换手率0.00%，振幅17.99%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。友芝友生物-B股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，北海康成-B、宜明昂科-B、友芝友生物-B涨幅较大，振幅较大的相关个股有华昊中天医药-B、华康生物医学、北海康成-B，振幅分别为22.86%、20.00%、19.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231114949ab98dbff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231114949ab98dbff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2494824217","title":"友芝友生物-B盘中异动 下午盘股价大涨17.61%报7.280港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494824217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494824217?lang=zh_cn&edition=full","pubTime":"2024-12-27 14:17","pubTimestamp":1735280246,"startTime":"0","endTime":"0","summary":"2024年12月27日下午盘14时17分，友芝友生物-B股票出现波动，股价急速上涨17.61%。截至发稿，该股报7.280港元/股，成交量3800股，换手率0.00%，振幅17.93%。资金方面，该股资金流入2.1006万港元，流出1456港元。友芝友生物-B股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，和铂医药-B、华康生物医学、东曜药业-B涨幅较大，振幅较大的相关个股有和铂医药-B、康宁杰瑞制药-B、东曜药业-B，振幅分别为27.27%、18.31%、16.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227141726a20b6a1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227141726a20b6a1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2493740553","title":"友芝友生物-B股价上涨13.48% 市值涨7212.47万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493740553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493740553?lang=zh_cn&edition=full","pubTime":"2024-12-24 10:27","pubTimestamp":1735007233,"startTime":"0","endTime":"0","summary":"2024年12月24日早盘10时27分，友芝友生物-B股票出现波动，股价大幅拉升13.48%。截至发稿，该股报4.800港元/股，成交量400股，换手率0.00%，振幅0.00%。资金方面，该股资金流入1920港元，流出0港元。友芝友生物-B股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，友芝友生物-B、腾盛博药-B、亚盛医药-B涨幅较大，振幅较大的相关个股有思路迪医药股份、腾盛博药-B、来凯医药-B，振幅分别为10.22%、7.22%、6.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122410271395eae959&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122410271395eae959&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2493978396","title":"友芝友生物-B盘中异动 下午盘快速拉升5.28%报4.190港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493978396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493978396?lang=zh_cn&edition=full","pubTime":"2024-12-23 13:42","pubTimestamp":1734932521,"startTime":"0","endTime":"0","summary":"2024年12月23日下午盘13时42分，友芝友生物-B股票出现异动，股价急速上涨5.28%。截至发稿，该股报4.190港元/股，成交量200股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出838港元。友芝友生物-B股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，腾盛博药-B、和铂医药-B、歌礼制药-B涨幅较大，振幅较大的相关个股有腾盛博药-B、乐普生物-B、和铂医药-B，振幅分别为15.29%、14.77%、10.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223134201ab8d0f7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223134201ab8d0f7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2492976207","title":"友芝友生物-B盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492976207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492976207?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:47","pubTimestamp":1734508023,"startTime":"0","endTime":"0","summary":"2024年12月18日临近收盘15时47分，友芝友生物-B股票出现波动，股价大幅上涨5.01%。截至发稿，该股报3.980港元/股，成交量7000股，换手率0.01%，振幅0.00%。资金方面，该股资金流入2.786万港元，流出0港元。友芝友生物-B股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，晶泰控股-P、歌礼制药-B、圣诺医药-B涨幅较大，振幅较大的相关个股有北海康成-B、晶泰控股-P、创胜集团-B，振幅分别为28.66%、25.84%、20.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218154705a1f7eca6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218154705a1f7eca6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02496"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.yzybio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0114},{"period":"3month","weight":0.2891},{"period":"6month","weight":0.6761},{"period":"1year","weight":0.8087},{"period":"ytd","weight":-0.1437}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"武汉友芝友生物制药股份有限公司是一家主要从事发现、开发及商业化抗肿瘤双特异性抗体方面的新型创新药物的中国公司。该公司致力于开发用于治疗癌症相关并发症、癌症及老年性眼科疾病的基于双特异性抗体（BsAb）疗法，以解决肿瘤学及老年眼科病领域的医疗需求。该公司的核心产品M701是一种靶向人癌细胞表面抗原EpCAM和人T细胞表面抗原CD3的重组BsAb。该公司的产品管线还包括Y101D、Y332、Y225等。","exchange":"SEHK","name":"友芝友生物-B","nameEN":"YZYBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"友芝友生物-B(02496)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供友芝友生物-B(02496)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"友芝友生物-B,02496,友芝友生物-B股票,友芝友生物-B股票老虎,友芝友生物-B股票老虎国际,友芝友生物-B行情,友芝友生物-B股票行情,友芝友生物-B股价,友芝友生物-B股市,友芝友生物-B股票价格,友芝友生物-B股票交易,友芝友生物-B股票购买,友芝友生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"友芝友生物-B(02496)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供友芝友生物-B(02496)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}